Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

September 19, 2018 06:00 ET | Source: Tetraphase Pharmaceuticals, Inc.

Tetraphase Pharmaceuticals to Present XERAVA™ (Eravacycline) and TP-6076 Data at IDWeek 2018

– Four Abstracts Selected for Poster Presentations – – TP-6076 Featured in Oral Presentation – WATERTOWN, Mass., Sept. 19, 2018 (GLOBE NEWSWIRE) -- Tetraphase Pharmaceuticals, Inc. (NASDAQ:TTPH),...
August 27, 2018 16:19 ET | Source: Tetraphase Pharmaceuticals, Inc.

Tetraphase Pharmaceuticals Announces FDA Approval of XERAVA™ (Eravacycline) for Complicated Intra-Abdominal Infections (cIAI)

– XERAVA™ Achieved High Clinical Cure Rates in Clinical Trials in Patients with cIAI – – Broad Product Label for Treatment of cIAI – – Commercial Launch Expected in the Fourth Quarter of 2018 – –...
August 27, 2018 12:00 ET | Source: Tetraphase Pharmaceuticals, Inc.

CORRECTING and REPLACING -- Tetraphase Pharmaceuticals to Participate at Upcoming Investor Conference

WATERTOWN, Mass., Aug. 27, 2018 (GLOBE NEWSWIRE) -- In a release issued earlier today by Tetraphase Pharmaceuticals, Inc. (NASDAQ:TTPH) please note that the upcoming investor conference details have...
August 27, 2018 06:00 ET | Source: Tetraphase Pharmaceuticals, Inc.

Tetraphase Pharmaceuticals to Participate at Upcoming Investor Conferences

WATERTOWN, Mass., Aug. 27, 2018 (GLOBE NEWSWIRE) -- Tetraphase Pharmaceuticals, Inc. (NASDAQ:TTPH), a biopharmaceutical company focused on developing and commercializing novel antibiotics to treat...
August 02, 2018 16:10 ET | Source: Tetraphase Pharmaceuticals, Inc.

Tetraphase Pharmaceuticals Reports Second Quarter 2018 Financial Results and Recent Highlights

WATERTOWN, Mass., Aug. 02, 2018 (GLOBE NEWSWIRE) -- Tetraphase Pharmaceuticals, Inc. (NASDAQ:TTPH), a biopharmaceutical company focused on developing and commercializing novel antibiotics to treat...
July 27, 2018 08:30 ET | Source: Tetraphase Pharmaceuticals, Inc.

Tetraphase Pharmaceuticals Receives Positive CHMP Opinion for Xerava™ (eravacycline) as a Treatment for Complicated Intra-Abdominal Infections

WATERTOWN, Mass., July 27, 2018 (GLOBE NEWSWIRE) -- Tetraphase Pharmaceuticals, Inc. (NASDAQ:TTPH), a biopharmaceutical company focused on developing and commercializing novel antibiotics to treat...
July 12, 2018 16:01 ET | Source: Tetraphase Pharmaceuticals, Inc.

Tetraphase Pharmaceuticals Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4)

WATERTOWN, Mass., July 12, 2018 (GLOBE NEWSWIRE) -- Tetraphase Pharmaceuticals, Inc. (NASDAQ:TTPH), a biopharmaceutical company focused on developing and commercializing novel antibiotics to treat...
June 11, 2018 06:30 ET | Source: Tetraphase Pharmaceuticals, Inc.

Tetraphase Pharmaceuticals Announces Data from a Pooled Analysis of IGNITE1 and IGNITE4 Phase 3 Trials Evaluating Eravacycline in Complicated Intra-Abdominal Infections at the ASM Microbe 2018 Annual Meeting

WATERTOWN, Mass., June 11, 2018 (GLOBE NEWSWIRE) -- Tetraphase Pharmaceuticals, Inc. (NASDAQ:TTPH), a biopharmaceutical company focused on developing and commercializing novel antibiotics to treat...
June 08, 2018 16:01 ET | Source: Tetraphase Pharmaceuticals, Inc.

Tetraphase Pharmaceuticals Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4)

WATERTOWN, Mass., June 08, 2018 (GLOBE NEWSWIRE) -- Tetraphase Pharmaceuticals, Inc. (NASDAQ:TTPH), a biopharmaceutical company focused on developing and commercializing novel antibiotics to treat...
June 04, 2018 06:00 ET | Source: Tetraphase Pharmaceuticals, Inc.

Tetraphase Pharmaceuticals Announces Everest Medicines’ Submission of an Investigational New Drug Application for Eravacycline in Complicated Intra-Abdominal Infection to the China Food and Drug Administration

WATERTOWN, Mass., June 04, 2018 (GLOBE NEWSWIRE) -- Tetraphase Pharmaceuticals, Inc. (NASDAQ:TTPH), a biopharmaceutical company focused on developing and commercializing novel antibiotics to treat...

keyboard_arrow_left Previous Page

Next Page keyboard_arrow_right